Research study Program year 2023 Source: CMS Open Payments

Nintedanib in PF ILD extension

Research payments

$2,533,004

213 payments

Through program year 2023, $2,533,004 in research payments was reported against Nintedanib in PF ILD extension, across 213 payments.

Paid by (largest first): Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$240,966	23
2022	Research	$191,474	40
2021	Research	$420,694	36
2020	Research	$826,599	60
2019	Research	$853,272	54

Breakdown

Who paid Research payments · program years 2019–2023

Boehringer Ingelheim Pharmaceuticals, Inc. $2,529,276 194 payments
Boehringer Ingelheim International GmbH $3,728 19 payments

Who received the money Research payments · program years 2019–2023

Mayo Clinic Organisation paid for research $196,174 5 payments
Johns Hopkins University Organisation paid for research $159,636 6 payments
Uc Davis Medical Center Teaching hospital · CA $146,592 7 payments
Duke University Organisation paid for research $137,827 6 payments
The Trustees Of Columbia University In Organisation paid for research $130,653 4 payments
Brigham And Womens Hospital Teaching hospital · MA $115,127 6 payments
The Univ of Texas Southwestern Med Ctr Organisation paid for research $104,052 4 payments
Inova Fairfax Hospital Teaching hospital · VA $87,056 4 payments
Mary Hitchcock Memorial Hosp Teaching hospital · NH $85,095 9 payments
Yale University School Of Medicine Organisation paid for research $75,447 5 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.